ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 65 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 14.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,256,000 | -14.8% | 1,820,129 | -36.4% | 0.00% | – |
| Q3 2020 | $1,474,000 | -49.9% | 2,862,433 | -28.6% | 0.00% | – |
| Q2 2020 | $2,944,000 | -28.8% | 4,007,747 | -9.6% | 0.00% | – |
| Q1 2020 | $4,135,000 | -59.8% | 4,430,998 | -12.1% | 0.00% | – |
| Q4 2019 | $10,289,000 | -40.0% | 5,043,638 | -15.6% | 0.00% | -100.0% |
| Q3 2019 | $17,152,000 | -63.9% | 5,976,237 | -3.5% | 0.00% | -50.0% |
| Q2 2019 | $47,495,000 | -48.0% | 6,192,271 | -9.9% | 0.00% | -50.0% |
| Q1 2019 | $91,294,000 | -4.0% | 6,869,362 | +12.6% | 0.00% | 0.0% |
| Q4 2018 | $95,090,000 | -10.1% | 6,103,355 | +13.3% | 0.00% | 0.0% |
| Q3 2018 | $105,806,000 | -23.8% | 5,384,536 | +11.3% | 0.00% | -33.3% |
| Q2 2018 | $138,875,000 | +33.8% | 4,838,847 | +10.3% | 0.01% | +20.0% |
| Q1 2018 | $103,780,000 | +10.5% | 4,388,188 | +0.3% | 0.01% | +25.0% |
| Q4 2017 | $93,877,000 | -6.8% | 4,376,589 | +2.7% | 0.00% | -20.0% |
| Q3 2017 | $100,750,000 | +18.7% | 4,260,058 | -1.1% | 0.01% | +25.0% |
| Q2 2017 | $84,871,000 | -2.4% | 4,308,160 | +4.1% | 0.00% | 0.0% |
| Q1 2017 | $86,931,000 | +18.4% | 4,139,589 | +6.0% | 0.00% | 0.0% |
| Q4 2016 | $73,433,000 | -12.6% | 3,906,014 | -2.9% | 0.00% | -20.0% |
| Q3 2016 | $83,994,000 | -22.9% | 4,022,754 | -5.8% | 0.01% | -28.6% |
| Q2 2016 | $108,872,000 | +17.3% | 4,268,679 | +21.6% | 0.01% | +16.7% |
| Q1 2016 | $92,825,000 | -33.9% | 3,509,422 | +6.9% | 0.01% | -33.3% |
| Q4 2015 | $140,480,000 | -74.2% | 3,283,773 | -79.1% | 0.01% | -55.0% |
| Q3 2015 | $545,256,000 | +425.1% | 15,741,228 | +405.3% | 0.02% | +185.7% |
| Q2 2015 | $103,836,000 | +4.5% | 3,115,389 | +4.3% | 0.01% | 0.0% |
| Q1 2015 | $99,366,000 | -14.5% | 2,985,775 | +5.0% | 0.01% | -12.5% |
| Q4 2014 | $116,202,000 | +21.3% | 2,843,213 | +0.6% | 0.01% | +14.3% |
| Q3 2014 | $95,800,000 | +2.2% | 2,827,624 | +1.6% | 0.01% | 0.0% |
| Q2 2014 | $93,779,000 | -10.8% | 2,781,919 | +0.3% | 0.01% | -22.2% |
| Q1 2014 | $105,129,000 | +35.6% | 2,773,141 | +4.4% | 0.01% | +28.6% |
| Q4 2013 | $77,543,000 | -10.5% | 2,655,596 | +5.0% | 0.01% | -12.5% |
| Q3 2013 | $86,673,000 | +7.1% | 2,528,390 | +3.1% | 0.01% | 0.0% |
| Q2 2013 | $80,928,000 | – | 2,453,113 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|